# Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit

> **NCT05348187** · NA · COMPLETED · sponsor: **QIAGEN Gaithersburg, Inc** · enrollment: 309 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer
- Colorectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** therascreen® KRAS RGQ PCR Kit

## Key facts

- **NCT ID:** NCT05348187
- **Lead sponsor:** QIAGEN Gaithersburg, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2020-11-23
- **Final completion:** 2020-11-23
- **Target enrollment:** 309 (ACTUAL)
- **Last updated:** 2024-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05348187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05348187, "Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05348187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*